Recombinant Hepatitis E Vaccine (Escherichia Coli)
- FOB Price:Get Latest Price >
- Min.Order:1 Vial(s)
- Payment Terms:L/C , T/T , Others
- Favorite
Product Information
- Dosage Form:Injection
- Route of Administration:Intramuscular Injection
- Shelf Life:3 years
- Storage:2℃-8℃
- Package:1 ml/ 1 pre-filled syringe/ 1 box
- Place of Origin:China
- Qualification:Chinese GMP
Description
Indications
It can stimulate the body to produce immunity against hepatitis E virus for the prevention of hepatitis E.
Highlights
1. The first Hepatitis E vaccine in the world , launched in 2012
2. 100% protection rate and good safety had been proven in large-scale phase III clinical trial(> 110000 subjects)
3. It’s predicted that immune persistence can last >10 years
4. Complete phase I, II, III clinical trial conducted in China
5. Being registered in India, Thailand, Nepal, Pakistan.
Specification
Each 0.5 ml dose contains 30μg of purified recombinant hepatitis E virus antigen.
Dosage Form
Solution for Injection
Package
1 ml/ 1 pre-filled syringe/ 1 box
Route of Administration
Intramuscular injection
Immunization schedule
3 doses of intramuscular injection following the 0, 1months, 6 months schedule
Target population
Age> 16 years
Shelf life
36 months
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank